A Feasibility Study of ApricityOncology Digital Therapeutics for Management of Immune-Related Adverse Events in Patients on Immuno-Oncology Therapy
Study of ApricityOncology Smartphone Application Monitoring and Reporting Side Effects to their Nurses and Doctors
Sponsor: Apricity Health, LLC
Enrolling: Male and Female Patients
IRB Number: AAAS3665
Contact: Research Nurse Navigator: 212-342-5162 / cancerclinicaltrials@cumc.columbia.edu
Additional Study Information: The purpose of this research study is to test how well a smartphone application (app), called ApricityCare, allows cancer patients being treated with immune-checkpoint therapy to monitor and report side effects to their oncology nurses and doctors. The app will also provide educational material to teach patients about side effects.
Investigator
Brian Henick, MD
Do You Qualify?
Are you at least 18 years old? Yes No
Have you been diagnosed with cancer? Yes No
Do you own a smartphone? Yes No
Are you comfortable with digital and/or mobile technology? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Research Nurse Navigator
cancerclinicaltrials@cumc.columbia.edu
212-342-5162